Bromelain 2400 Gdu

Bromelain 2400 GDU is a proteolytic enzyme extract derived from pineapple stem, standardised to a minimum activity of 2400 Gelatin Digesting Units per gram. This particular listing from Apex Biotechnol offers the enzyme in a concentrated form suitable for industrial formulation, with the 2400 GDU grade indicating a mid-to-high potency level suitable for pharmaceutical and nutraceutical applications. The enzyme functions by hydrolysing peptide bonds, a property that requires careful handling and precise dosing in finished products.

The typical preparation involves aqueous extraction from Ananas comosus followed by filtration, concentration, and standardisation to the declared activity. Standard industry grades range from 600 GDU for food-grade tenderising applications up to 2500+ GDU for specialised pharmaceutical use, placing this 2400 GDU offering near the upper end of commercial availability. Activity stability depends on pH, temperature, and the presence of stabilising agents; typical optimal activity occurs between pH 4.0 and 9.0 with temperature optima around 50-60°C, though supplier-specific stability data should be requested for formulation work.

Primary buyers include dietary supplement manufacturers seeking digestive enzymes, pharmaceutical formulators developing anti-inflammatory or debridement products, and food processors requiring meat tenderisation or brewing clarification. The powder form specified here suits direct compression tableting or capsule filling after appropriate excipient selection. Importers should verify with Apex Biotechnol the exact carrier or excipient used for standardisation, as maltodextrin or other inert bases commonly constitute 30-70% of the final powder by weight and affect formulation calculations.

Apex Biotechnol operates from Indore, Madhya Pradesh, India, with a listed address at 682 Shanti Vill, Ashok Nagar. The company carries a Harbor trust tier designation on the platform, which represents a baseline verification level rather than an advanced accreditation. Notably, the supplier displays a 0.00% response rate with zero average response hours recorded, indicating either a newly registered account, inactive status, or a data reporting gap that prospective buyers should investigate before committing to enquiry.

The supplier profile provides no stated history, manufacturing capacity, employee count, revenue figures, or named clientele. No certifications are independently verifiable from the listing data alone. Buyers should treat the ISO and FDA references in the source description as claims requiring direct documentation from Apex Biotechnol rather than assumed facts. The listing positions the company as a supplier of enzymatic products for pharmaceutical, food, and supplement industries, but the extent of their manufacturing versus trading activity is unspecified.